- Home
- PGC vs ORGO Comparison
PGC vs ORGO Comparison
Compare PGC & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGC
- ORGO
- Stock Information
- Founded
- PGC 1921
- ORGO 1985
- Country
- PGC United States
- ORGO United States
- Employees
- PGC N/A
- ORGO N/A
- Industry
- PGC Commercial Banks
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- PGC Finance
- ORGO Health Care
- Exchange
- PGC Nasdaq
- ORGO Nasdaq
- Market Cap
- PGC 536.5M
- ORGO 620.3M
- IPO Year
- PGC N/A
- ORGO N/A
- Fundamental
- Price
- PGC $25.70
- ORGO $4.17
- Analyst Decision
- PGC Strong Buy
- ORGO Buy
- Analyst Count
- PGC 2
- ORGO 3
- Target Price
- PGC $37.00
- ORGO $7.33
- AVG Volume (30 Days)
- PGC 139.3K
- ORGO 582.2K
- Earning Date
- PGC 10-22-2025
- ORGO 11-06-2025
- Dividend Yield
- PGC 0.75%
- ORGO N/A
- EPS Growth
- PGC 6.12
- ORGO N/A
- EPS
- PGC 1.93
- ORGO N/A
- Revenue
- PGC $248,809,000.00
- ORGO $429,531,000.00
- Revenue This Year
- PGC $29.31
- ORGO $2.51
- Revenue Next Year
- PGC $18.30
- ORGO $25.45
- P/E Ratio
- PGC $13.32
- ORGO N/A
- Revenue Growth
- PGC 18.63
- ORGO N/A
- 52 Week Low
- PGC $23.96
- ORGO $2.61
- 52 Week High
- PGC $37.88
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- PGC 39.37
- ORGO 46.63
- Support Level
- PGC $25.62
- ORGO $4.04
- Resistance Level
- PGC $27.47
- ORGO $4.39
- Average True Range (ATR)
- PGC 1.07
- ORGO 0.16
- MACD
- PGC -0.12
- ORGO 0.04
- Stochastic Oscillator
- PGC 4.36
- ORGO 60.00
About PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.